On August 14, GENSCRIPT BIO fell 3.31% in regular trading, trading at HK$25.12/share, with turnover of HK$262 million.
Within the Life Sciences Tools & Services sector where GENSCRIPT BIO belongs, stocks broadly weakened. Among individual stocks, INSILICO down 3.84%, XTALPI down 3.66%, WUXI APPTEC down 3.30%, PHARMARON down 2.76%, WUXI BIO down 0.92%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)